BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24513177)

  • 41. Role of estrogen receptor gene demethylation and DNA methyltransferase.DNA adduct formation in 5-aza-2'deoxycytidine-induced cytotoxicity in human breast cancer cells.
    Ferguson AT; Vertino PM; Spitzner JR; Baylin SB; Muller MT; Davidson NE
    J Biol Chem; 1997 Dec; 272(51):32260-6. PubMed ID: 9405430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple roles of COUP-TFII in cancer initiation and progression.
    Litchfield LM; Klinge CM
    J Mol Endocrinol; 2012 Dec; 49(3):R135-48. PubMed ID: 22966133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The orphan receptor COUP-TFII regulates G2/M progression of breast cancer cells by modulating the expression/activity of p21(WAF1/CIP1), cyclin D1, and cdk2.
    Nakshatri H; Mendonca MS; Bhat-Nakshatri P; Patel NM; Goulet RJ; Cornetta K
    Biochem Biophys Res Commun; 2000 Apr; 270(3):1144-53. PubMed ID: 10772965
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA methylation of retinoic acid receptor beta in breast cancer and possible therapeutic role of 5-aza-2'-deoxycytidine.
    Bovenzi V; Lê NL; Côte S; Sinnett D; Momparler LF; Momparler RL
    Anticancer Drugs; 1999 Jun; 10(5):471-6. PubMed ID: 10477167
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.
    Li Y; Meeran SM; Patel SN; Chen H; Hardy TM; Tollefsbol TO
    Mol Cancer; 2013 Feb; 12():9. PubMed ID: 23379261
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetic inactivation of the SFRP1 gene in esophageal squamous cell carcinoma.
    Meng Y; Wang QG; Wang JX; Zhu ST; Jiao Y; Li P; Zhang ST
    Dig Dis Sci; 2011 Nov; 56(11):3195-203. PubMed ID: 21567192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin-like growth factor binding protein-3 (IGFBP-3) plays a role in the anti-tumorigenic effects of 5-Aza-2'-deoxycytidine (AZA) in breast cancer cells.
    Zeng L; Jarrett C; Brown K; Gillespie KM; Holly JM; Perks CM
    Exp Cell Res; 2013 Aug; 319(14):2282-95. PubMed ID: 23810988
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of trichostatin A and 5-Aza-2'-deoxycytidine on transgene reactivation and epigenetic modification in transgenic pig fibroblast cells.
    Kong Q; Wu M; Wang Z; Zhang X; Li L; Liu X; Mu Y; Liu Z
    Mol Cell Biochem; 2011 Sep; 355(1-2):157-65. PubMed ID: 21541675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-density array analysis of DNA methylation in Tamoxifen-resistant breast cancer cell lines.
    Williams KE; Anderton DL; Lee MP; Pentecost BT; Arcaro KF
    Epigenetics; 2014 Feb; 9(2):297-307. PubMed ID: 24225485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on P16, hMLH1 and MGMT genes and DNA methylation in human gastric cancer cells].
    Meng CF; Zhu XJ; Dai DQ; Peng G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):494-7. PubMed ID: 19742343
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of 5-aza-2'- deoxycytidine and trichostatin A on gene expression and DNA methylation status in cloned bovine blastocysts.
    Wang Y; Su J; Wang L; Xu W; Quan F; Liu J; Zhang Y
    Cell Reprogram; 2011 Aug; 13(4):297-306. PubMed ID: 21486115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
    Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
    PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells.
    Heller G; Schmidt WM; Ziegler B; Holzer S; Müllauer L; Bilban M; Zielinski CC; Drach J; Zöchbauer-Müller S
    Cancer Res; 2008 Jan; 68(1):44-54. PubMed ID: 18172295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The INSL3 gene is a direct target for the orphan nuclear receptor, COUP-TFII, in Leydig cells.
    Mendoza-Villarroel RE; Di-Luoffo M; Camiré E; Giner XC; Brousseau C; Tremblay JJ
    J Mol Endocrinol; 2014 Aug; 53(1):43-55. PubMed ID: 24780841
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
    Meng CF; Zhu XJ; Peng G; Dai DQ
    Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synergistic antineoplastic action of DNA methylation inhibitor 5-AZA-2'-deoxycytidine and histone deacetylase inhibitor depsipeptide on human breast carcinoma cells.
    Primeau M; Gagnon J; Momparler RL
    Int J Cancer; 2003 Jan; 103(2):177-84. PubMed ID: 12455031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines.
    Meng CF; Zhu XJ; Peng G; Dai DQ
    World J Gastroenterol; 2007 Dec; 13(46):6166-71. PubMed ID: 18069755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Altered methylation of glucosylceramide synthase promoter regulates its expression and associates with acquired multidrug resistance in invasive ductal breast cancer.
    Liu J; Zhang X; Liu A; Zhang D; Su Y; Liu Y; You D; Yuan L; Kong X; Wang X; Sun P
    Oncotarget; 2016 Jun; 7(24):36755-36766. PubMed ID: 27191984
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decitabine (5-Aza-2'-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells.
    Ando T; Nishimura M; Oka Y
    Leukemia; 2000 Nov; 14(11):1915-20. PubMed ID: 11069027
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Coup-TFII orphan nuclear receptor is an activator of the γ-globin gene.
    Fugazza C; Barbarani G; Elangovan S; Marini MG; Giolitto S; Font-Monclus I; Marongiu MF; Manunza L; Strouboulis J; Cantù C; Gasparri F; Barabino SML; Nakamura Y; Ottolenghi S; Moi P; Ronchi AE
    Haematologica; 2021 Feb; 106(2):474-482. PubMed ID: 32107331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.